Found: 134
Select item for more details and to access through your institution.
Regulatory watch: Outcomes of EMA marketing authorization applications: does partnering have an influence?
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 12, p. 878, doi. 10.1038/nrd4468
- By:
- Publication type:
- Article
Appropriate evidence for adaptive marketing authorization.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Appropriate evidence for adaptive marketing authorization.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 647, doi. 10.1038/nrd4114
- By:
- Publication type:
- Article
Factors influencing non-approval of new drugs in Europe.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 12, p. 903, doi. 10.1038/nrd3894
- By:
- Publication type:
- Article
Switching TNFα inhibitors: Patterns and determinants.
- Published in:
- Pharmacology Research & Perspectives, 2021, v. 9, n. 4, p. 1, doi. 10.1002/prp2.843
- By:
- Publication type:
- Article
Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.948161
- By:
- Publication type:
- Article
Reasons for and time to discontinuation of rimonabant therapy: a modified prescription-event monitoring study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Reasons for and Time to Discontinuation of Rimonabant Therapy A Modified Prescription-Event Monitoring Study.
- Published in:
- Drug Safety, 2012, v. 35, n. 12, p. 1147, doi. 10.2165/11631330-000000000-00000
- By:
- Publication type:
- Article
A cohort study exploring determinants of safety-related regulatory actions for biopharmaceuticals.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Randomized controlled trials of COX-2 inhibitors: an analysis of doses used and trends over time to investigate implications for comparative safety.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Safety-related regulatory actions for orphan drugs in the US and EU: a cohort study.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Evaluation of post-authorization safety studies in the first cohort of EU Risk Management Plans at time of regulatory approval.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Pharmacovigilance of biopharmaceuticals: challenges remain.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Drug-related nephrotoxic and ototoxic reactions : a link through a predictive mechanistic commonality.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Determinants of headache in lansoprazole users in The Netherlands: results from a nested case-control study.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Tenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghana.
- Published in:
- BMC Research Notes, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13104-019-4454-2
- By:
- Publication type:
- Article
Drug development for exceptionally rare metabolic diseases: challenging but not impossible.
- Published in:
- 2013
- By:
- Publication type:
- journal article
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products--a pilot study.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 6, p. 883, doi. 10.1007/s40258-019-00496-1
- By:
- Publication type:
- Article
Risk of Aplastic Anemia in Patients Using Antiepileptic Drugs.
- Published in:
- Epilepsia (Series 4), 2006, v. 47, n. 7, p. 1232, doi. 10.1111/j.1528-1167.2006.00596.x
- By:
- Publication type:
- Article
Impact of medicine shortages on patients - a framework and application in the Netherlands.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of medicine shortages on patients - a framework and application in the Netherlands.
- Published in:
- BMC Health Services Research, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12913-022-08765-x
- By:
- Publication type:
- Article
Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 2369, doi. 10.2147/PPA.S116860
- By:
- Publication type:
- Article
Hematocytometry analysis as discriminative marker for asthma phenotypes.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2009, v. 47, n. 5, p. 573, doi. 10.1515/CCLM.2009.139
- By:
- Publication type:
- Article
Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2007, v. 45, n. 10, p. 1326, doi. 10.1515/CCLM.2007.268
- By:
- Publication type:
- Article
Reimbursement Restriction and Moderate Decrease in Benzodiazepine Use in General Practice.
- Published in:
- Annals of Family Medicine, 2012, v. 10, n. 1, p. 42, doi. 10.1370/afm.1319
- By:
- Publication type:
- Article
Reimbursement restriction and moderate decrease in benzodiazepine use in general practice.
- Published in:
- 2012
- By:
- Publication type:
- journal article
What Drives Prescribing of Asthma Medication to Children? A Multilevel Population-Based Study.
- Published in:
- Annals of Family Medicine, 2009, v. 7, n. 1, p. 32, doi. 10.1370/afm.910
- By:
- Publication type:
- Article
Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, p. 19, doi. 10.1111/dom.13453
- By:
- Publication type:
- Article
Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 401, doi. 10.1111/dom.12833
- By:
- Publication type:
- Article
Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 421, doi. 10.1111/dom.12843
- By:
- Publication type:
- Article
Uptake of orphan drugs in the WHO essential medicines lists.
- Published in:
- Bulletin of the World Health Organization, 2024, v. 102, n. 1, p. 22, doi. 10.2471/BLT.23.289731
- By:
- Publication type:
- Article
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries.
- Published in:
- Bulletin of the World Health Organization, 2014, v. 92, n. 9, p. 630, doi. 10.2471/BLT.13.129114
- By:
- Publication type:
- Article
"Rare essentials": drugs for rare diseases as essential medicines.
- Published in:
- Bulletin of the World Health Organization, 2006, v. 84, n. 9, p. 745, doi. 10.2471/BLT.06.031518
- By:
- Publication type:
- Article
The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0143800
- By:
- Publication type:
- Article
Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0106072
- By:
- Publication type:
- Article
Essential Medicines Are More Available than Other Medicines around the Globe.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087576
- By:
- Publication type:
- Article
Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0075550
- By:
- Publication type:
- Article
The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072060
- By:
- Publication type:
- Article
Risk of Death and Cardiovascular Outcomes with Thiazolidinediones: A Study with the General Practice Research Database and Secondary Care Data.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028157
- By:
- Publication type:
- Article
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement.
- Published in:
- International Journal of Technology Assessment in Health Care, 2023, v. 39, n. 1, p. 1, doi. 10.1017/S0266462323000144
- By:
- Publication type:
- Article
Addressing uncertainty in relative effectiveness assessments by HTA organizations.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, n. 1, p. 1, doi. 10.1017/S026646232100177X
- By:
- Publication type:
- Article
Addressing uncertainty in relative effectiveness assessments by HTA organizations.
- Published in:
- International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S026646232100177X
- By:
- Publication type:
- Article
Getting the Right Evidence After Drug Approval.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.569535
- By:
- Publication type:
- Article
Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 5, p. 2169, doi. 10.1111/bcp.15141
- By:
- Publication type:
- Article
Post‐marketing dosing changes in the label of biologicals.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 4, p. 715, doi. 10.1111/bcp.13843
- By:
- Publication type:
- Article
Comparing safety information of biosimilars with their originators: a cross‐sectional analysis of European risk management plans.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 4, p. 738, doi. 10.1111/bcp.13454
- By:
- Publication type:
- Article
Pharmacological vs. classical approaches in the design of first in man clinical drug trials.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 12, p. 2807, doi. 10.1111/bcp.13422
- By:
- Publication type:
- Article